Literature DB >> 1474860

Cloricromene antagonizes antidipsogenic effects induced by endotoxin, but not by TNF alpha, in the rat.

G Calapai1, G Mazzaglia, M C Marciano, F Squadrito, D Altavilla, B Zingarelli, M Prosdocimi, A P Caputi.   

Abstract

Intravenous (640 micrograms/kg) or intracerebroventricular (0.5 and 1 microgram) injection of Escherichia coli endotoxin (LPS) causes inhibition of water intake induced by 24 hour period of water deprivation in the rat. Tumor necrosis factor alpha (TNF-alpha; 20 and 40 ng/rat) given into the lateral cerebral ventricle (i.c.v.) causes effects similar to those observed after LPS. Cloricromene, given either intravenously (1 and 2 mg/kg) or i.c.v. (250 and 500 ng), abolished the antidipsogenic effect induced by LPS (administered both i.v. and i.c.v.). Cloricromene (2 mg/kg, i.v. or 500 ng/rat, i.c.v.), on the contrary, did not modify the antidipsogenic effects induced by TNF-alpha. These data indicate that peripherally injected cloricromene (as well as that i.c.v. injected) antagonizes the effects of mediators of LPS on sites regulating thirst and suggest that cloricromene's action may be due to inhibition of brain TNF-alpha formation induced by LPS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474860     DOI: 10.1016/0024-3205(92)90154-h

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

Review 1.  Participation of α2 -adrenoceptors in sodium appetite inhibition during sickness behaviour following administration of lipopolysaccharide.

Authors:  Laurival A De Luca; Roberto L Almeida; Richard B David; Patricia M de Paula; Carina A F Andrade; José V Menani
Journal:  J Physiol       Date:  2015-07-07       Impact factor: 5.182

2.  Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat.

Authors:  G Calapai; G Mazzaglia; M Cilia; B Zingarelli; F Squadrito; A P Caputi
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.